
    
      165 subjects, 5-75 years old with mild to moderate Atopic Dermatitis will be enrolled to the
      study.

      The investigational product which is the synthetic analogue of the natural compound found in
      the rattle snake venom will be administered topically twice daily.

      The duration of the study will be up to 17 weeks consisting of up to 3 weeks of screening, 12
      weeks of treatment, followed by 2 weeks of follow-up.

      Efficacy will be measured by IGA (Investigator Global Assessment, EASI (Eczema Area and
      Severity Index) and SCORAD (SCORing Atopic Dermatitis).

      Lesions will be photographed throughout the study. Physical examination and vital signs will
      be measured during every visit. Patients will complete quality of life questionnaires,
      itching scale and diaries.
    
  